Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris D Poole

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
BMJ Open|October 25, 2011
Evaluation of the incremental cost to the National Health Service of prescribing analogue insulinSarah E Holden, Chris D Poole, Christopher Ll Morgan, et al.
Rheumatology (Oxford, England)|June 29, 2010
Estimation of health care costs as a function of disease severity in people with psoriatic arthritis in the UKChris D Poole, Max Lebmeier, Roberta Ara, et al.
The Journal of Clinical Endocrinology and Metabolism|February 2, 2013
Mortality and other important diabetes-related outcomes with insulin vs other antihyperglycemic therapies in type 2 diabetesCraig J Currie, Chris D Poole, Marc Evans, et al.
Journal of Crohn'S & Colitis|December 3, 2010
A comparison of physician-rated disease severity and patient reported outcomes in mild to moderately active ulcerative colitisChris D Poole, Mark P Connolly, Sandy Kildegaard Nielsen, et al.
Health and Quality of Life Outcomes|November 8, 2011
Deriving health state utilities for the numerical pain rating scaleSimon Dixon, Chris D Poole, Isaac Odeyemi, et al.
Current Medical Research and Opinion|July 28, 2006
Multivariate models of health-related utility and the fear of hypoglycaemia in people with diabetesCraig J Currie, Christopher Ll Morgan, Chris D Poole, et al.
Health and Quality of Life Outcomes|June 15, 2014
Estimation of health-related utility (EQ-5D index) in subjects with seasonal allergic rhinoconjunctivitis to evaluate health gain associated with sublingual grass allergen immunotherapyChris D Poole, Christian A Bannister, Jakob Nørgaard Andreasen, et al.
Journal of Crohn'S & Colitis|December 22, 2010
An economic evaluation comparing once daily with twice daily mesalazine for maintaining remission based on results from a randomised controlled clinical trialMark P Connolly, Sandy K Nielsen, Craig J Currie, et al.
Child and Adolescent Psychiatry and Mental Health|October 15, 2013
The prevalence and incidence, resource use and financial costs of treating people with attention deficit/hyperactivity disorder (ADHD) in the United Kingdom (1998 to 2010)Sarah E Holden, Sara Jenkins-Jones, Chris D Poole, et al.
Clinical Therapeutics|May 1, 2021
Characterization and Associated Costs of Constipation Relating to Exposure to Strong Opioids in England: An Observational StudyChristopher Ll Morgan, Sara Jenkins-Jones, Roger Knaggs, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
BMJ Open|October 25, 2011
Evaluation of the incremental cost to the National Health Service of prescribing analogue insulinSarah E Holden, Chris D Poole, Christopher Ll Morgan, et al.
Rheumatology (Oxford, England)|June 29, 2010
Estimation of health care costs as a function of disease severity in people with psoriatic arthritis in the UKChris D Poole, Max Lebmeier, Roberta Ara, et al.
The Journal of Clinical Endocrinology and Metabolism|February 2, 2013
Mortality and other important diabetes-related outcomes with insulin vs other antihyperglycemic therapies in type 2 diabetesCraig J Currie, Chris D Poole, Marc Evans, et al.
Journal of Crohn'S & Colitis|December 3, 2010
A comparison of physician-rated disease severity and patient reported outcomes in mild to moderately active ulcerative colitisChris D Poole, Mark P Connolly, Sandy Kildegaard Nielsen, et al.
Health and Quality of Life Outcomes|November 8, 2011
Deriving health state utilities for the numerical pain rating scaleSimon Dixon, Chris D Poole, Isaac Odeyemi, et al.
Current Medical Research and Opinion|July 28, 2006
Multivariate models of health-related utility and the fear of hypoglycaemia in people with diabetesCraig J Currie, Christopher Ll Morgan, Chris D Poole, et al.
Health and Quality of Life Outcomes|June 15, 2014
Estimation of health-related utility (EQ-5D index) in subjects with seasonal allergic rhinoconjunctivitis to evaluate health gain associated with sublingual grass allergen immunotherapyChris D Poole, Christian A Bannister, Jakob Nørgaard Andreasen, et al.
Journal of Crohn'S & Colitis|December 22, 2010
An economic evaluation comparing once daily with twice daily mesalazine for maintaining remission based on results from a randomised controlled clinical trialMark P Connolly, Sandy K Nielsen, Craig J Currie, et al.
Child and Adolescent Psychiatry and Mental Health|October 15, 2013
The prevalence and incidence, resource use and financial costs of treating people with attention deficit/hyperactivity disorder (ADHD) in the United Kingdom (1998 to 2010)Sarah E Holden, Sara Jenkins-Jones, Chris D Poole, et al.
Clinical Therapeutics|May 1, 2021
Characterization and Associated Costs of Constipation Relating to Exposure to Strong Opioids in England: An Observational StudyChristopher Ll Morgan, Sara Jenkins-Jones, Roger Knaggs, et al.
Pageof 4